MTX pathway gene variants, erythrocyte methotrexate polyglutamates, and treatment outcomes in rheumatoid arthritis.

Wang P, Liang C, Lin L, Lan J, Zhang Y, Xie W

Open source

DOI
10.17305/bb.2026.13544
Published
2026 Jan 19
Container
Biomolecules & biomedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17305/bb.2026.13544,
  title = {MTX pathway gene variants, erythrocyte methotrexate polyglutamates, and treatment outcomes in rheumatoid arthritis.},
  author = {Wang P and Liang C and Lin L and Lan J and Zhang Y and Xie W},
  year = {2026},
  journal = {Biomolecules \& biomedicine},
  doi = {10.17305/bb.2026.13544},
  url = {https://doi.org/10.17305/bb.2026.13544}
}

RIS

TY  - JOUR
TI  - MTX pathway gene variants, erythrocyte methotrexate polyglutamates, and treatment outcomes in rheumatoid arthritis.
AU  - Wang P
AU  - Liang C
AU  - Lin L
AU  - Lan J
AU  - Zhang Y
AU  - Xie W
PY  - 2026
JO  - Biomolecules & biomedicine
DO  - 10.17305/bb.2026.13544
UR  - https://doi.org/10.17305/bb.2026.13544
ER  - 

APA

P, W., C, L., L, L., J, L., Y, Z., & W, X. (2026). MTX pathway gene variants, erythrocyte methotrexate polyglutamates, and treatment outcomes in rheumatoid arthritis.. Biomolecules & biomedicine. https://doi.org/10.17305/bb.2026.13544

Source records